BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34423401)

  • 1. ASO Author Reflections: The Role of Oncolytic Virotherapy in Advanced Gastrointestinal Cancers.
    LaRocca CJ; Yamamoto M
    Ann Surg Oncol; 2021 Dec; 28(13):8565-8566. PubMed ID: 34423401
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancer.
    Huang F; Wang BR; Wu YQ; Wang FC; Zhang J; Wang YG
    World J Gastroenterol; 2016 Sep; 22(35):7999-8009. PubMed ID: 27672294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer.
    Fujiwara T; Shirakawa Y; Kagawa S
    Expert Rev Anticancer Ther; 2011 Apr; 11(4):525-32. PubMed ID: 21504319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic virotherapy.
    Russell SJ; Peng KW; Bell JC
    Nat Biotechnol; 2012 Jul; 30(7):658-70. PubMed ID: 22781695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.
    Guan M; Romano G; Coroniti R; Henderson EE
    J Exp Clin Cancer Res; 2014 Nov; 33():91. PubMed ID: 25366264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mathematical model of oncolytic virotherapy with time delay.
    Wang ZZ; Guo ZM; Smith H
    Math Biosci Eng; 2019 Mar; 16(4):1836-1860. PubMed ID: 31137188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic Virotherapy by HSV.
    Watanabe D; Goshima F
    Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic virotherapy meets the human organoid technology for pancreatic cancers.
    Fiorini E; Corbo V
    EBioMedicine; 2020 Jul; 57():102828. PubMed ID: 32574953
    [No Abstract]   [Full Text] [Related]  

  • 9. Can Surgeons Expand the Role of Oncolytic Viruses for Cancer Treatment? An Editorial Comment on "Fighting Fire with Fire: Oncolytic Virotherapy in Thoracic Malignancies".
    Kaufman HL
    Ann Surg Oncol; 2021 May; 28(5):2432-2433. PubMed ID: 33475883
    [No Abstract]   [Full Text] [Related]  

  • 10. Oncolytic virotherapy for urological cancers.
    Delwar Z; Zhang K; Rennie PS; Jia W
    Nat Rev Urol; 2016 Jun; 13(6):334-52. PubMed ID: 27215429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is oncolytic virotherapy?
    Cockle JV; Scott KJ
    Arch Dis Child Educ Pract Ed; 2018 Feb; 103(1):43-45. PubMed ID: 28588023
    [No Abstract]   [Full Text] [Related]  

  • 12. Oncolytic Virotherapy and Gene Therapy Strategies for Hepatobiliary Cancers.
    Yamada T; Hamano Y; Hasegawa N; Seo E; Fukuda K; Yokoyama KK; Hyodo I; Abei M
    Curr Cancer Drug Targets; 2018; 18(2):188-201. PubMed ID: 28359239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic Virotherapy for Malignant Tumor: Current Clinical Status.
    Zhang Y; Liu Z
    Curr Pharm Des; 2019; 25(40):4251-4263. PubMed ID: 31682207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses.
    Saito K; Shirasawa H; Isegawa N; Shiiba M; Uzawa K; Tanzawa H
    Oral Oncol; 2009 Dec; 45(12):1021-7. PubMed ID: 19833547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. United virus: the oncolytic tag-team against cancer!
    Le Boeuf F; Bell JC
    Cytokine Growth Factor Rev; 2010; 21(2-3):205-11. PubMed ID: 20227326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The two-faces of NK cells in oncolytic virotherapy.
    Marotel M; Hasim MS; Hagerman A; Ardolino M
    Cytokine Growth Factor Rev; 2020 Dec; 56():59-68. PubMed ID: 32586674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalizing oncolytic virotherapy?
    Kaur B; Chiocca EA
    Mol Ther; 2007 Jan; 15(1):6-7. PubMed ID: 17164767
    [No Abstract]   [Full Text] [Related]  

  • 18. Attack of the cancer-killing viruses: clinical application of oncolytic virotherapy in children.
    Friedman GK
    Pediatr Blood Cancer; 2015 May; 62(5):739-40. PubMed ID: 25663349
    [No Abstract]   [Full Text] [Related]  

  • 19. Designer nanocarriers for navigating the systemic delivery of oncolytic viruses.
    Howard F; Muthana M
    Nanomedicine (Lond); 2020 Jan; 15(1):93-110. PubMed ID: 31868115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Killer Cells Recruitment in Oncolytic Virotherapy: A Mathematical Model.
    Senekal NS; Mahasa KJ; Eladdadi A; de Pillis L; Ouifki R
    Bull Math Biol; 2021 May; 83(7):75. PubMed ID: 34008149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.